| Nf1-dependent tumors require a microenvironment containing Nf1+/−-and c-kit-dependent bone marrow FC Yang, DA Ingram, S Chen, Y Zhu, J Yuan, X Li, X Yang, S Knowles, ... Cell 135 (3), 437-448, 2008 | 402 | 2008 |
| Advances in immuno–positron emission tomography: antibodies for molecular imaging in oncology SM Knowles, AM Wu Journal of Clinical Oncology 30 (31), 3884, 2012 | 220 | 2012 |
| Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo R Tavaré, MN McCracken, KA Zettlitz, SM Knowles, FB Salazar, T Olafsen, ... Proceedings of the National Academy of Sciences 111 (3), 1108-1113, 2014 | 195 | 2014 |
| Individually ventilated cages impose cold stress on laboratory mice: a source of systemic experimental variability JM David, S Knowles, DM Lamkin, DB Stout Journal of the American Association for Laboratory Animal Science 52 (6 …, 2013 | 82 | 2013 |
| Quantitative immunoPET of prostate cancer xenografts with 89Zr-and 124I-labeled anti-PSCA A11 minibody SM Knowles, KA Zettlitz, R Tavaré, MM Rochefort, FB Salazar, DB Stout, ... Journal of Nuclear Medicine 55 (3), 452-459, 2014 | 62 | 2014 |
| Fluorescent image–guided surgery with an anti-prostate stem cell antigen (PSCA) diabody enables targeted resection of mouse prostate cancer xenografts in real time GA Sonn, AS Behesnilian, ZK Jiang, KA Zettlitz, EJ Lepin, LA Bentolila, ... Clinical Cancer Research 22 (6), 1403-1412, 2016 | 53 | 2016 |
| ImmunoPET of Malignant and Normal B Cells with 89Zr- and 124I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization In Vivo KA Zettlitz, R Tavaré, SM Knowles, KK Steward, JM Timmerman, AM Wu Clinical Cancer Research 23 (23), 7242-7252, 2017 | 52 | 2017 |
| Tuning the serum persistence of human serum albumin domain III: diabody fusion proteins VE Kenanova, T Olafsen, FB Salazar, LE Williams, S Knowles, AM Wu Protein Engineering, Design & Selection 23 (10), 789-798, 2010 | 52 | 2010 |
| Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti–Prostate Stem Cell Antigen Cys-Diabody KA Zettlitz, WTK Tsai, SM Knowles, N Kobayashi, TR Donahue, RE Reiter, ... Journal of Nuclear Medicine 59 (9), 1398-1405, 2018 | 46 | 2018 |
| Applications of ImmunoPET: Using 124I-Anti-PSCA A11 Minibody for Imaging Disease Progression and Response to Therapy in Mouse Xenograft Models of … SM Knowles, R Tavaré, KA Zettlitz, MM Rochefort, FB Salazar, ZK Jiang, ... Clinical Cancer Research 20 (24), 6367-6378, 2014 | 38 | 2014 |
| Endocytosis and intracellular trafficking properties of transferrin-conjugated block copolypeptide vesicles UJ Choe, AR Rodriguez, BS Lee, SM Knowles, AM Wu, TJ Deming, ... Biomacromolecules 14 (5), 1458-1464, 2013 | 31 | 2013 |
| Engineering A11 minibody-conjugated, polypeptide-based gold nanoshells for prostate stem cell antigen (PSCA)–targeted photothermal therapy KM Mayle, KR Dern, VK Wong, KY Chen, S Sung, K Ding, AR Rodriguez, ... SLAS TECHNOLOGY: Translating Life Sciences Innovation 22 (1), 26-35, 2017 | 16 | 2017 |
| A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts MM Rochefort, MD Girgis, SM Knowles, JS Ankeny, F Salazar, AM Wu, ... Molecular imaging and biology 16, 721-729, 2014 | 15 | 2014 |
| Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging MQ Wilks, SM Knowles, AM Wu, SC Huang Journal of Nuclear Medicine 55 (9), 1539-1544, 2014 | 14 | 2014 |
| [89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model KA Zettlitz, WTK Tsai, SM Knowles, FB Salazar, N Kobayashi, RE Reiter, ... Molecular imaging and biology 22, 367-376, 2020 | 7 | 2020 |
| P1130: Frontline brentuximab vedotin and CHP (A+ CHP) in patients with peripheral T-cell lymphoma with less than 10% CD30 expression: Initial safety and efficacy results from … S Iyer, D Jagadeesh, ED Domènech, F Benedetti, AR Izquierdo, ... HemaSphere 7 (S3), e4008899, 2023 | 2 | 2023 |
| Efficacy and Safety of Retreatment with Brentuximab Vedotin in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or CD30-Expressing Peripheral T Cell Lymphoma D Sano, S Ahmed, J Liu, S Knowles, ST Lee Blood 140 (Supplement 1), 12003-12004, 2022 | 2 | 2022 |
| Murine brown fat metabolism measured by infrared thermography correlates with PET FDG uptake J David, S Knowles, R Taschereau, A Chatziioannou, D Stout Journal of Nuclear Medicine 54 (supplement 2), 1120-1120, 2013 | 2 | 2013 |
| FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+ CHP) IN PATIENTS WITH PERIPHERAL T‐CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION (SGN35‐032, TRIAL IN PROGRESS) D Jagadeesh, S Knowles, SM Horwitz Hematological Oncology 39, 2021 | 1 | 2021 |
| Quantitative in vivo imaging of slowly diffusing radiotracers M Wilks, S Knowles, A Wu, SC Huang Journal of Nuclear Medicine 54 (supplement 2), 48-48, 2013 | 1 | 2013 |
Anna M. WuProfessor and Chair, Immunology & Theranostics, City of HopeVerified email at coh.org
